RE:RE:RE:RE:RE:RE:RE:AGM CEO Presentation....
That is alot of information on why the chart was bad for many years prior to 2014. But for any new investor they care about the here and now and the prospects for the future. What I am able to find out is that they have a marketing submission for full approval of their 100% owned bladder cancer treatment in 5-6 months. And that the market values this at less than 40 million Canadian. For people who have held the company for years blaming the old management might relieve the pain but new investors really don't care to know much about their vaccine and animal business from a totally different group of executives. They want to know what is happening now as in today and why the share price is so very very poor. Why is the stock 20 cents? that is really all anyone should care about. You can't keep a full marketing approval application with the FDA secret but it looks you can scare people away from believing it has a chance of getting approved.